徐之昇(Hsu, Chih-Sheng) 副教授

Email
jasonhsu@tmu.edu.tw
現   職
國際生技醫療管理博士學位學程 副教授
管理學院健康產業數據加值研究中心 主任
臨床數據中心 主任

學經歷

學 歷

畢業學校與學位[修業時間]
國立臺灣大學管理學院國際企業學系 博士
2007/09~2013/01
國立清華大學科技管理研究所 碩士
2002/09~2004/06
臺北醫學大學藥學系 學士
1998/09~2002/06

本校學術經歷

任職單位與職稱[起迄時間]
國際生技醫療管理博士學位學程副教授
2021/08/01~
國際生技醫療管理博士學位學程助理教授
2020/08/01~2021/07/31
(舊)國際生技醫療管理博士學位學程籌備處助理教授
2020/02/01~2020/07/31

本校兼職教學行政經歷

服務單位與職稱[起迄時間]
管理學院健康產業數據加值研究中心主任
2021/11/10 ~
臨床數據中心主任
2021/08/01 ~
(舊)管理學院大數據研究中心主任
2021/08/01 ~ 2021/11/09
大數據科技及管理研究所助理教授
2021/04/01 ~
數據處副數據長
2020/08/01 ~ 2021/07/31

其它經歷

任職單位與職稱[起迄時間]
國立成功大學助理教授
2014/08/01~2020/01/31

專長與研究領域

學門領域
產業前瞻技術計畫
產業前瞻技術計畫
新興/其他領域
新興/其他領域
藥學
Pharmacy
公衛及環境醫學
Public Health and Environmental Medicine
學術專長
人口健康
人口健康
食品與藥物管理
食品與藥物管理
健康保險
健康保險
電腦模擬
電腦模擬
藥事經濟暨專利分析
藥事經濟暨專利分析

論文著作

清冊下載


1. 2024 Huang, C.F.,Kuo, T.T.,Hsu, J.C.*,Kosik, R.O.,Chan, W.P.*. Anti-osteoporosis Drugs Reduce Mortality in Cancer Patients: A National Cohort Study of Elderly with Vertebral Fractures . Annals, Academy of Medicine, Singapore .2024

2. 2024 Hien, N.T.K.,Tsai1, F.J.,Chang, Y.H.,Burton, W.,Phuc, P.T.,Nguyen, P.-A.; Harnod, D.; Lam, C.S.K.; Lu, T.C.; Chen, C.I.; Hsu, M.H.; Lu, C.Y.; Huang, C.W.; Yang, H.C.; Hsu, J.C.*. Unveiling the Future of COVID-19 Patient Care: Groundbreaking Prediction Models for Severe Outcomes or Mortality in Hospitalized Cases . Frontiers in Medicine .2024

3. 2023 You, S.C.,Seo, S.I.,Falconer, T.,Yanover, C.,Duarte-Salles, T.,Seager, S.; Posada, J.D.; Shah, N.H.; Nguyen, P.A.; Kim, Y.; Hsu, J.C.; Zandt, M.V.; Hsu, M.H.; Lee, H.L.; Ko, H.; Shin, W.G.; Pratt, N.; Park, R.W.; Reich, C.G.; Suchard, M.M.; Hripcsak, G.; Park, C.H.; Prieto-Alhambra, D.. Ranitidine use and incident cancer in a multinational cohort . JAMA Network Open .2023

4. 2023 Hsu, S.W.,Chiang, S.C.,Hsu, J.C.,Ko, Y.*. Prescription patterns of granulocyte colony–stimulating factors in patients with breast cancer: a real-world study . PLOS One .2023

5. 2023 Lee, H.L.,Cheng, P.L.,Wu, P.H.,Kao, W.Y.,Lai, Y.T.,Hsu, J.C.; Chiou, J.F.; Wu, M.H.. Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: A systematic review and meta-analysis . Experimental Hematology & Oncology .2023

6. 2023 Wu, P.N.,Chen, J.H.,Yang, C.P.,Hsu, J.C.*. Advantages of DES over BMS in preventing the risk of myocardial infarction, ischemic stroke and mortality in various populations . Journal of Clinical Medicine .2023

7. 2023 Wu, M.H.#,Hsu, J.C.#,Kim, J.S.,Huang, T.J.,Huang, Y.H.,Yiu, H.P.; Lee, C.Y.; Tani, J.*; Chang, C.C.*. Near infrared imaging system for preventing blood vision obstruction in endoscopy . Optics Express .2023

8. 2023 Chen, S.M.,Phuc, P.T.,Nguyen, P.A.,Lin, S.J.,Lin, W.C.,Lu, C.Y.; Hsu, M.H.; Cheng, C.T.; Hsu, J.C.*. A novel prediction model of the risk of pancreatic cancer among diabetes patients using multiple clinical data and machine learning . Cancer Medicine .2023

9. 2023 Quynh, N.T.N.,Wang, C.J.,Nguyen, P.A.,Phuc, P.T.,Lin, R.K.,Hung, C.S.; Kuo, N.H.; Cheng, Y.W.; Cheng, C.T.; Hsu, M.H.*; Hsu, J.C.*. Machine Learning and Deep Learning Approaches for Predicting 5-year Survival of Patients with Breast Cancer . Cancer Science .2023

10. 2023 Weng, H.C.,Chang, S.M.,Hsu, J.C.,Yang, Y.N.,Lin, C.Y.. Age and gender differences in misperceptions of body shape in a Taiwanese population . Journal of Eating Disorders .2023

11. 2023 Huang, C.W.,Wu, B.C.Y.,Nguyen, P.A.,Wang, H.H.,Kao, C.C.,Lee, P.C.; Rahmanti, A.R.; Hsu, J.C.; Yang, H.C.; Li, Y.C.J.. Emotion recognition in doctor-patient interactions from real-world clinical video database: Initial development of artificial empathy . Computer Methods and Programs in Biomedicine .2023

12. 2022 Lu, Y.,Zandt, M.V.,Liu, Y.,Li, J.,Wang, X.,Chen, Y.; Chen, Z.; Cho, J.; Dorajoo, S.R.; Feng, M.; Hsu, M.H.; Hsu, J.C.; Iqbal, U.; Jonnagaddala, J.; Li, Y.C.; Liaw, S.T.; Lim, H.S.; Ngiam, K.Y.; Nguyen, P.A.; Park, R.W.; Pratt, N.; Reich, C.; Rhee, S.Y.; Sathappan, S.M.K.; Shin, S.J.; Tan, H.X.; You, S.C.; Zhang, X.; Krumholz, H.M.; Suchard, M.A.; Xu, H.. Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort . JAMA Network Open .2022 ;(5)

13. 2022 Li, C.C.#,Hsu, J.C.#,Liang, F.W.,Chang, Y.F.,Chiu, C.J.*,Wu, C.H.*. The association between osteoporosis medications and lowered all-cause mortality after hip or vertebral fracture in older and oldest-old adults: A nationwide population-based study . Aging .2022 ;(14):2239-2251

14. 2022 Hsu, Y.H.,Li, C.C.,Liang, F.W.,Peng, Z.Y.,Chang, Y.F.,Hsu, J.C.; Ou, H.T.; Wu, C.H.. Reduced all-cause mortality with bisphosphonates among post-fracture osteoporosis patients: a nationwide study and systematic review . Clinical Pharmacology & Therapeutics .2022

15. 2022 Tai, T.W.,Hwang, J.S.,Li, C.C.,Hsu, J.C.,Chang, C.W.,Wu, C.H.. The impact of various anti-osteoporosis drugs on all-cause mortality after hip fractures: A nationwide population study . Journal of Bone and Mineral Research .2022

16. 2022 Lin, W.K.,Lin, S.J.,Lee, W.R.,Lin, C.C.,Lin, W.C.,Chang, H.C.; Cheng, C.T.; Hsu, J.C.*. Effectiveness and safety of immunosuppressants and biological therapy for chronic spontaneous urticaria: a network meta-analysis . Biomedicines .2022

17. 2022 Chan, T.C.,Pai, C.W.,Wu, C.C.,Hsu, J.C.,Chen, R.J.,Chiu, W.T.; Lam, C.. Association of Air Pollution and Weather Factors with Traffic Injury Severity: A Study in Taiwan . International Journal of Environmental Research and Public Health .2022

18. 2022 Peng, H.Y.,Lin, Y.K.,Nguyen, P.A.,Hsu, J.C.*,Chou, C.L.,Chang, C.C.; Lin, C.C.; Lam, C.; Chen, C.I.; Wang, K.H.; Lu, C.Y.. Determinants of COVID-19 infection by artificial intelligence technology: a study of 28 countries . PLOS One .2022

19. 2022 Chiou, K.,Chiu, Y.C.,Lee, C.Y.,Huang, T.J.,Lai, Y.C.,Yang, C.J.; Hsu, J.C.*; Wu, M.H.*. Comparison of long-term outcomes of spinal fusion surgeries supplemented with “topping-off” implants in lumbar degenerative diseases: a systematic review and network meta-analysis . North American Spine Society Journal .2022

20. 2022 Hsu, J.C.,Nguyen, P.-A.,Phuc, P.T.,Lo, T.C.,Hsu, M.H.,Hsieh, M.S.; Le, N.Q.K.; Cheng, C.T.; Chang, T.H.*; Chen, C.Y.*. Development and Validation of Novel Deep-Learning Models using Multiple Data Types for Lung Cancer Survival . Cancers .2022

21. 2022 Nguyen, N.T.H.,Huang, C.W.,Wang, C.H.,Lin, M.C.,Hsu, J.C.,Hsu, M.H.; Iqbal, U.; Nguyen, P.-A. Yang, H.C.*. Association Between Proton Pump Inhibitor Use and the Risk of Female . Cancers .2022

22. 2022 Wu, P.N.,Chen, J.H.,Yang, C.P.,Hsu, J.C.*. Advantages of DES over BMS in preventing the risk of myocardial infarction, ischemic stroke and mortality in various populations . Journal of Clinical Medicine .2022

23. 2022 Chiang, P.L.,Chen, Y.Y.,Chen, K.T.,Hsu, J.C.,Wu, C.,Lee, C.Y.; Huang, T.J.; Huang, Y.H.; Chen, C.M.; Wu, M.H.*. Comparison Between Lumbar Endoscopic Unilateral Laminotomy for Bilateral Decompression and Other Decompression Approaches for Lumbar Spinal Stenosis: A Systematic Review . World Neurosurgery .2022

24. 2021 Poon, S.Y.K.,Hsu, J.C.,Ko, Y.,Chiang, S.C.*. Assessing Knowledge and Attitude of Healthcare Professionals on Biosimilars: A National Survey for Pharmacists and Physicians in Taiwan . Healthcare .2021

25. 2021 Hung, S.A.,Liao, C.L.,Lin, W.P.,Hsu, J.C.,Guo, Y.H.,Lin, Y.C.*. Botulinum Toxin Injections for Treatment of Drooling in Children with Cerebral Palsy: A Systematic Review and Meta-analysis . Children .2021

26. 2021 許育煊,李佳純,梁富文,張尹凡,徐之昇*,吳至行*. 雙磷酸鹽類藥物使用對骨鬆骨折病人死亡率的影響-健保資料庫分析 . 台灣家庭醫學雜誌 .2021 ;(31):199-213

27. 2021 雙磷酸鹽類藥物使用對骨鬆骨折病人死亡率的影響-健保資料庫分析 . 台灣家庭醫學雜誌 .2021 ;(31):199-213

28. 2021 Poon, S.Y.K.,Hsu, J.C.,Ko, Y.,Chiang, S.C.. Assessing Knowledge and Attitude of Healthcare Professionals on Biosimilars: A National Survey for Pharmacists and Physicians in Taiwan . Healthcare .2021

29. 2021 Chen, J.H.,Wu, P.N.,Huang, S.C.,Hsu, P.J.,Hsu, J.C.. A Real-World Observational Study of Drug Utilization and Clinical Outcomes of Direct-acting Antivirals and Interferon Therapy for Hepatitis C Treatment in Taiwan . Current Medical Research and Opinion .2021

30. 2021 Chang, W.C.,Lin, A.Y.,Hsu, J.C.,Wu, C.E,Goh, C.,Chou, P.; Kuo, K.; Chang, A.; Palencia, R.. A cost-utility analysis of avelumab for metastatic Merkel cell carcinoma in Taiwan . Cancer Reports .2021

31. 2021 Tseng, P.,Tsai, F.J.,Hsu, J.C.,Chang, Y.C.,Wang, K.H.,Wu, M.K.; Chen, M.; Su, C.H.; Shia, B.C.; Miser, J.S.. Public Awareness as a Line of Defense against COVID-19 in Taiwan . Asia Pacific Journal of Public Health .2021

32. 2021 Hsu, J.C.,Nguyen, P.A.,Chen, Y.T.,Yang, S.C.,Lin, C.C.,Yang, Y.H.; Lin, Y.C.; Hsia, T.C.; Hsieh, H.C.; Wu, J.S.; Chang, C.P.; Feng, Y.H.; Lin, P.C.; Hsu, P.C.; Tzeng, H.E.; Chien, S.C.; Chang, W.C.; Chang, C.C.; Yang, H.C.; Lee, C.M.; Lu, C.Y.. The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients with Stage III/IV: A multicenter study . Frontiers in Oncology .2021

33. 2021 Qin, L.,Zhang, X.,Wu, A.,Miser, J.S.,Liu, Y.L.,Hsu, J.C.; Shia, B.C.; Ye, L.. Association of Social Media with Cancer Screening Awareness and Behavior for People without a Cancer Diagnosis: Matched Cohort Study . Journal of Medical Internet Research .2021

34. 2020 Yang SC,Lai WW,Hsu JC,Su WC,Wang JD. Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan . PLOS One .2020

35. 2020 Hsu, J.C.,Tseng, Y.C.,Chang, S.M.,Lee, Y.C.,Lin, P.C.,Chu, H.J.. Health Inequality: A Longitudinal Study on Geographic Variations in Lung Cancer Incidence and Mortality in Taiwan . BMC Public Health .2020

36. 2020 Hsu JC,Wei CF,Yang SC,Lin PC,Lee YC,Lu CY. Lung Cancer Survival and Mortality in Taiwan following the Initial Launch of Targeted Therapies: An Interrupted Time Series Study . BMJ Open .2020 ;(10)

37. 2019 Hsu JC,Lin JY,Lin PC,Lee YC. Comprehensive Value Assessment of Drugs using a Multi-Criteria Decision Analysis: An Example of Targeted Therapies for Metastatic Colorectal Cancer Treatment . PLOS One .2019

38. 2019 Wu KL,Wu CH,Chang YF,Lin YT,Hsu JC. Budget Impact Analysis of Osteoporosis Medications for Primary Prevention of Fractures in Taiwan . Journal of Bone and Mineral Metabolism .2019

39. 2019 Hsu JC,Wei CF,Yang SC. Effects of Removing Reimbursement Restrictions on Targeted Therapy Accessibility for Non-small Cell Lung Cancer Treatment in Taiwan: an Interrupted Time Series Study . BMJ Open .2019

40. 2018 Hsu JC,Wu HC,Feng WC,Chou CH,Lai ECC,Lu CY. Disease and Economic Burden for Rare Diseases in Taiwan: A Longitudinal Study Using Taiwan’s National Health Insurance Research Database . PLOS One .2018

41. 2018 Chen HY,Chiu PY,Chang CJ,Tsao LL,Huang YL,Hsu JC. Replacement Effects and Budget Impacts of Insurance Coverage for Sodium-glucose Cotransporter-2 Inhibitors on Oral Antidiabetic Drug Utilization . Clinical Drug Investigation .2018

42. 2018 Hsu JC,Lin JY,Hsu MY,Lin PC. Effectiveness and Safety of Immune Checkpoint Inhibitors: A Retrospective Study in Taiwan . PLOS One .2018

43. 2018 Hsu JC,Su YC,Tang BY,Lu CY. Use of Assisted Reproductive Technologies before and after the Artificial Reproduction Act in Taiwan . PLOS One .2018

44. 2017 Hsu JC,Chang SM,Lu CY. Geographic Variations and Time Trends in Cancer Treatments in Taiwan . BMC Public Health .2017

45. 2017 Hsieh HC,Hsu JC,Lu CY. 10-year trends in statin utilization in Taiwan: a retrospective study using Taiwan’s National Health Insurance Research Database . BMJ Open .2017

46. 2017 Hsu JC,Hsieh CL,Lu CY. Trend and Geographic Analysis of Prevalence of Dengue in Taiwan (2010-2015) . International Journal of Infectious Diseases .2017

47. 2016 Hsu JC,Lu CY. Longitudinal Trends in Use and Costs of Targeted Therapies for Common Cancers in Taiwan: A Retrospective Observational Study . BMJ Open .2016

48. 2016 Longitudinal Trends in Targeted Therapies Use for Treatment of Malignant Neoplasms of The Eye: A Population-based Study in Taiwan . BMJ Open .2016

49. 2016 Hsu JC,Gonzalez-Gonzalez LA,Lu VH,Lu CY. Longitudinal Trends in Targeted Therapies Use for Treatment of Malignant Neoplasms of The Eye: A Population-based Study in Taiwan . BMJ Open .2016

50. 2015 Hsu JC,Hsieh CY,Yang Kao YH,Lu CY. Net Clinical Benefit of Oral Anticoagulants: A Multiple Criteria Decision Analysis . PLOS One .2015

51. 2015 Hsu JC,Tang DH,Lu CY. Risk-Benefit Assessment of Oral Phosphodiesterase Type 5 Inhibitors for treatment of Erectile Dysfunction: A Multiple Criteria Decision Analysis . International Journal of Clinical Practice .2015

52. 2015 Hsu JC,Cheng CL,Ross-Degnan D,Wagner AK,Zhang F,Kao Yang YH, Liu LL, Tai HY, Chen KH, Yang PW, Lu CY. Effects of Safety Warnings and Risk Management Plan for Thiazolidinediones in Taiwan . Pharmacoepidemiology and Drug Safety .2015

53. 2015 Hsu JC,Ross-Degnan D,Wagner AK,Zhang F,Lu CY. How did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid? . Clinical Therapeutics .2015

54. 2015 Hsu JC,Lu CY. The Evolution of Taiwan’s National Health Insurance Drug Reimbursement Scheme . DARU Journal of Pharmaceutical Sciences .2015

55. 2015 Hsu JC,Ross-Degnan D,Wagner AK,Cheng CL,Kao Yang YH,Zhang F, Lu CY. Utilization of Oral Antidiabetic Medications in Taiwan following Strategies to Promote Access to Medicines for Chronic Diseases in Community Pharmacies . Journal of Pharmaceutical Policy and Practice .2015

56. 2014 Hsu JC,Lu CY,Wagner A,Chan KW,Lai MS,Ross-Degnan D. Impacts of Drug Reimbursement Reductions on Utilization and Expenditures of Oral Antidiabetic Medications in Taiwan: An Interrupted Time Series Study . Health Policy .2014

57. 2014 Cheng CL,Chao PH,Hsu JC,Weng MMY,On AWF,Yang Kao YH. Utilization Patterns of Anti-hyperuricemic Agents Following Safety Announcement on Allopurinol and Benzbromarone by Taiwan Food and Drug Administration . Pharmacoepidemiology and Drug Safety .2014


1. 2022 Hsu, J.C.*,Lu, C.Y.. Evidence on the Utility and Limitations of Artificial Intelligence for Predicting Personalized Disease Prognosis and Treatment Decisions . Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy .2022

2. 2022 Hsu, J.C.*,Lu, C.Y.. Evidence on the Utility and Limitations to Using AI for Personalized Drug Safety Prediction . Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy .2022

研究計畫

計畫名稱
113 「補助國內舉辦國際學術研討會」2024健康數據科學年會
補助單位
國家科學及技術委員會

計畫名稱
113 新冠肺炎重症、死亡、長期併發症的影響因素及個人化預測模型 – 國內外真實世界數據之運用 (第二、三年延續性計畫)
補助單位
國家科學及技術委員會

計畫名稱
113 「補助國內研究生出席國際學術會議」申請費用補助案(研究生:保健營養學系博士班NGUYEN THI KIM HIEN君)
補助單位
國家科學及技術委員會

計畫名稱
112 運用我國醫院臨床數據建立高血壓患者 失智症風險預測模型
補助單位
國家科學及技術委員會

計畫名稱
112 Real World Evaluation of nirmatrelvir/ritonavir in Taiwan using hospital EMR
補助單位
輝瑞大藥廠股份有限公司

計畫名稱
112 Hyperkalemia in Real-World Patients Under medical care in Taiwan (Hyper-K TW)研究計畫
補助單位
臺灣阿斯特捷利康股份有限公司

計畫名稱
112 新冠肺炎重症、死亡、長期併發症的影響因素及個人化預測模型 – 國內外真實世界數據之運用
補助單位
國家科學及技術委員會

計畫名稱
112 會議名稱:2023 OHDSI Global Symposium
補助單位
國家科學及技術委員會

計畫名稱
112 「補助國內研究生出席國際學術會議」申請費用補助案(研究生:藥學系(所)博士班NGUYEN THI NHU QUYNH君)
補助單位
國家科學及技術委員會

計畫名稱
112 「補助國內研究生出席國際學術會議」申請費用補助案(研究生:藥學系(所)博士班Christianus Heru Setiawan君)
補助單位

計畫名稱
112 「補助國內研究生出席國際學術會議」申請費用補助案 ( 研究生:國際生技醫療管理博士學位學程博士班 Whitney Burton 君 )
補助單位
國家科學及技術委員會

計畫名稱
111 2022 OHDSI亞太地區年會
補助單位
國家科學及技術委員會

計畫名稱
111 第三屆OHDSI亞太地區年會
補助單位
教育部

計畫名稱
111 運用我國醫院臨床數據探討COVID感染導致呼吸衰竭的影響因素 Using Taiwan hospital clinical data to explore the influencing factor
補助單位
國家科學及技術委員會

計畫名稱
111 會議名稱:2022 OHDSI 研討會
補助單位
國家科學及技術委員會

計畫名稱
111 會議名稱:OHDSI Symposium Collaborator Showcase
補助單位
國家科學及技術委員會

計畫名稱
111 會議名稱:MedInfo 2023
補助單位
國家科學及技術委員會

計畫名稱
111 會議名稱:醫學信息 2023
補助單位
國家科學及技術委員會

計畫名稱
111 會議名稱:2023 OHDSI 亞太 (APAC) 研討會。
補助單位
國家科學及技術委員會

計畫名稱
111 會議名稱:2023 年觀察健康數據科學信息學 (OHDSI) 亞太地區研討會
補助單位
國家科學及技術委員會

計畫名稱
110 顆粒性白血球生長刺激素之臨床結果與健康經濟分析
補助單位
暉致醫藥股份有限公司

計畫名稱
110 發炎性腸道疾病研究可行性諮詢研究計畫
補助單位
艾昆緯藥品資訊股份有限公司

計畫名稱
110 發炎性腸道疾病研究可行性諮詢研究計畫
補助單位
艾昆緯藥品資訊股份有限公司

計畫名稱
108 新聘教師研究補助
補助單位
臺北醫學大學

計畫名稱
108 台灣癌症防治結果之健康不平等研究: 疾病負擔、經濟負擔、醫療可近性及臨床結果
補助單位
科技部

計畫名稱
107 晚期肺癌病患使用免疫療法之生活品質評估
補助單位
科技部